- Report
- August 2025
- 376 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 367 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 377 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 376 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 483 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 381 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 480 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 270 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 470 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 377 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 268 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 458 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 283 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 469 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 382 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 372 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 372 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 274 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 393 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 384 Pages
Global
From €5208EUR$5,850USD£4,501GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more